Publication Information

{'id': 'https://openalex.org/W2461402164', 'doi': None, 'title': '[THE STUDY OF ANXIOLYTIC PROPERTIES OF NEW PYRAZOLO[C]PYRIDINE DERIVATIVE GIZH-72].', 'display_name': '[THE STUDY OF ANXIOLYTIC PROPERTIES OF NEW PYRAZOLO[C]PYRIDINE DERIVATIVE GIZH-72].', 'publication_year': 2015, 'publication_date': '2015-01-01', 'ids': {'openalex': 'https://openalex.org/W2461402164', 'mag': '2461402164', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/27017697'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/27017697', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5041991975', 'display_name': 'Kudryashov Nv', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Kudryashov Nv', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5047799351', 'display_name': 'Т. С. Калинина', 'orcid': 'https://orcid.org/0000-0002-0178-3567'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Kalinina Ts', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5014466526', 'display_name': 'Александр Александрович Шимширт', 'orcid': 'https://orcid.org/0000-0001-6913-3248'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Shimshirt Aa', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5091891926', 'display_name': 'Korolev Ao', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Korolev Ao', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5070065617', 'display_name': 'Volkova Av', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Volkova Av', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5023228846', 'display_name': 'Zhmurenko La', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Zhmurenko La', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5059695206', 'display_name': 'Voroninal Ta', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Voroninal Ta', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 1, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 66, 'max': 73}, 'biblio': {'volume': '78', 'issue': '11', 'first_page': '3', 'last_page': '7'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10274', 'display_name': 'Heterocyclic Compounds for Drug Discovery', 'score': 0.9486, 'subfield': {'id': 'https://openalex.org/subfields/1605', 'display_name': 'Organic Chemistry'}, 'field': {'id': 'https://openalex.org/fields/16', 'display_name': 'Chemistry'}, 'domain': {'id': 'https://openalex.org/domains/3', 'display_name': 'Physical Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10274', 'display_name': 'Heterocyclic Compounds for Drug Discovery', 'score': 0.9486, 'subfield': {'id': 'https://openalex.org/subfields/1605', 'display_name': 'Organic Chemistry'}, 'field': {'id': 'https://openalex.org/fields/16', 'display_name': 'Chemistry'}, 'domain': {'id': 'https://openalex.org/domains/3', 'display_name': 'Physical Sciences'}}, {'id': 'https://openalex.org/T12410', 'display_name': 'Heterocyclic Chemistry Synthesis', 'score': 0.9267, 'subfield': {'id': 'https://openalex.org/subfields/1605', 'display_name': 'Organic Chemistry'}, 'field': {'id': 'https://openalex.org/fields/16', 'display_name': 'Chemistry'}, 'domain': {'id': 'https://openalex.org/domains/3', 'display_name': 'Physical Sciences'}}, {'id': 'https://openalex.org/T13454', 'display_name': 'Biological Activities of Phenothiazines and Related Compounds', 'score': 0.9264, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/elevated-plus-maze', 'display_name': 'Elevated plus maze', 'score': 0.59241194}, {'id': 'https://openalex.org/keywords/pyrazoles', 'display_name': 'Pyrazoles', 'score': 0.439651}], 'concepts': [{'id': 'https://openalex.org/C2777765862', 'wikidata': 'https://www.wikidata.org/wiki/Q62903', 'display_name': 'Anxiolytic', 'level': 3, 'score': 0.78209645}, {'id': 'https://openalex.org/C2779085643', 'wikidata': 'https://www.wikidata.org/wiki/Q7096029', 'display_name': 'Open field', 'level': 2, 'score': 0.75141025}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.7182236}, {'id': 'https://openalex.org/C2776175493', 'wikidata': 'https://www.wikidata.org/wiki/Q210402', 'display_name': 'Diazepam', 'level': 2, 'score': 0.6719645}, {'id': 'https://openalex.org/C173586616', 'wikidata': 'https://www.wikidata.org/wiki/Q5359685', 'display_name': 'Elevated plus maze', 'level': 3, 'score': 0.59241194}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.506918}, {'id': 'https://openalex.org/C2776134451', 'wikidata': 'https://www.wikidata.org/wiki/Q422244', 'display_name': 'Fluoxetine', 'level': 4, 'score': 0.4518669}, {'id': 'https://openalex.org/C15744967', 'wikidata': 'https://www.wikidata.org/wiki/Q9418', 'display_name': 'Psychology', 'level': 0, 'score': 0.37432534}, {'id': 'https://openalex.org/C558461103', 'wikidata': 'https://www.wikidata.org/wiki/Q154430', 'display_name': 'Anxiety', 'level': 2, 'score': 0.36196977}, {'id': 'https://openalex.org/C170493617', 'wikidata': 'https://www.wikidata.org/wiki/Q208467', 'display_name': 'Receptor', 'level': 2, 'score': 0.33527413}, {'id': 'https://openalex.org/C134018914', 'wikidata': 'https://www.wikidata.org/wiki/Q162606', 'display_name': 'Endocrinology', 'level': 1, 'score': 0.283544}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.22434425}, {'id': 'https://openalex.org/C2775864247', 'wikidata': 'https://www.wikidata.org/wiki/Q167934', 'display_name': 'Serotonin', 'level': 3, 'score': 0.16372675}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.16075498}, {'id': 'https://openalex.org/C118552586', 'wikidata': 'https://www.wikidata.org/wiki/Q7867', 'display_name': 'Psychiatry', 'level': 1, 'score': 0.08564091}], 'mesh': [{'descriptor_ui': 'D014151', 'descriptor_name': 'Anti-Anxiety Agents', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D014151', 'descriptor_name': 'Anti-Anxiety Agents', 'qualifier_ui': 'Q000737', 'qualifier_name': 'chemistry', 'is_major_topic': True}, {'descriptor_ui': 'D001007', 'descriptor_name': 'Anxiety', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D001007', 'descriptor_name': 'Anxiety', 'qualifier_ui': 'Q000503', 'qualifier_name': 'physiopathology', 'is_major_topic': True}, {'descriptor_ui': 'D000818', 'descriptor_name': 'Animals', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014151', 'descriptor_name': 'Anti-Anxiety Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014151', 'descriptor_name': 'Anti-Anxiety Agents', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D001007', 'descriptor_name': 'Anxiety', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D051379', 'descriptor_name': 'Mice', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008807', 'descriptor_name': 'Mice, Inbred BALB C', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D051381', 'descriptor_name': 'Rats', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017208', 'descriptor_name': 'Rats, Wistar', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/27017697', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Peace, justice, and strong institutions', 'id': 'https://metadata.un.org/sdg/16', 'score': 0.47}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W2991953983', 'https://openalex.org/W2980335556', 'https://openalex.org/W2808825382', 'https://openalex.org/W2768452677', 'https://openalex.org/W2461402164', 'https://openalex.org/W2181324467', 'https://openalex.org/W2083814207', 'https://openalex.org/W2047039000', 'https://openalex.org/W2038331423', 'https://openalex.org/W2036863060'], 'abstract_inverted_index': {'It': [0, 45], 'was': [1, 142], 'studied': [2], 'the': [3, 63, 89, 100, 127, 134, 138, 145], 'anxiolytic': [4, 60], 'properties': [5, 148], 'of': [6, 39, 91, 106, 131, 147, 149, 156], '4,6-dimethyl-2-(4-chlorophenyl)-2,3-dihydro-1Í-pyrazolo[4,3-c]pyridin-3-one': [7], 'chloralhydrate': [8], '(GIZh-72,': [9], '20': [10], 'mg/kg,': [11, 16, 23, 28], 'i.p.)': [12, 17, 24, 29], 'and': [13, 25, 32, 43, 54, 97, 108], 'afobazole': [14, 81, 107], '(1': [15, 27], 'in': [18, 30, 62, 78, 94, 116, 137], 'comparison': [19], 'to': [20, 104, 122], 'fluoxetine': [21], '(20': [22], 'diazepam': [26, 79], 'open-field': [31, 64], 'marble': [33], 'burying': [34], 'tests': [35], 'on': [36], 'male': [37, 117], 'mice': [38], 'inbred': [40], 'strains': [41], 'BALB/C': [42, 83, 96], 'C57BL/6.': [44], 'is': [46], 'established': [47], 'that': [48, 105], 'GIZh-72': [49, 73, 120], 'administered': [50], 'both': [51, 95], '30': [52], 'min': [53], '24': [55], 'h': [56], 'before': [57], 'testing': [58], 'produces': [59], 'effect': [61, 101], 'test.': [65], 'The': [66], 'open': [67], 'field': [68], 'anxiety': [69], 'response': [70], 'patterns': [71], 'following': [72], 'administration': [74], 'differed': [75], 'from': [76], 'these': [77], 'or': [80, 124], 'treated': [82], 'mice.': [84], 'This': [85], 'drug': [86, 112], 'also': [87], 'decreased': [88], 'number': [90], 'buried': [92], 'marbles': [93], 'C57BL/6': [98], 'mice,': [99], 'being': [102], 'comparable': [103], 'fluoxetine.': [109], 'In': [110], 'operant': [111], 'discrimination': [113], 'liquid-reinforcement': [114], 'paradigm': [115], 'Wistar': [118], 'rats,': [119], 'failed': [121], 'antagonize': [123], 'substitute': [125], 'for': [126, 144], 'interoceptive': [128], 'stimulus': [129], 'cues': [130], 'pentylenetetrazole': [132], 'evoking': [133], 'saline-like': [135], 'responses': [136], 'latter': [139], 'case,': [140], 'which': [141], 'evidence': [143], 'absence': [146], 'a': [150], 'ligand': [151], 'bearing': [152], 'positive': [153], 'modulator': [154], 'sites': [155], 'GABA-A': [157], 'receptor.': [158]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2461402164', 'counts_by_year': [{'year': 2020, 'cited_by_count': 1}], 'updated_date': '2024-09-25T22:44:06.340786', 'created_date': '2016-07-22'}